Related Experiment Video

Updated: May 9, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28

Frederick L Locke1, Yuan-yuan Zha, Yan Zheng

  • 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|July 16, 2013
PubMed

Insights

Deleting PTEN in T cells enhances their activation, cytokine production, and cytotoxic activity but does not affect their survival or make them independent of CD28 costimulation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • PTEN (phosphatase and tensin homolog) is a key negative regulator of the PI3K/Akt signaling pathway.
  • This pathway is crucial for T cell activation, proliferation, and survival.
  • Understanding PTEN's role in T cells is vital for developing immunotherapies.

Purpose of the Study:

  • To investigate the functional consequences of PTEN deletion in postthymic T cells.
  • To determine if PTEN inhibition can enhance T cell responses for therapeutic applications.

Main Methods:

  • Utilized CAR transgenic × PTEN(flox/flox) mice for inducible PTEN deletion in T cells via Cre adenovirus.
  • Generated and analyzed PTEN-deleted T cell clones (Th1 and CD8).
  • Assessed T cell activation, proliferation, cytokine production (IL-2), Akt phosphorylation, survival, gene expression, and cytolytic activity.

Main Results:

  • PTEN-deleted T cells showed enhanced IL-2 production, proliferation, and Akt phosphorylation upon stimulation.
  • T cell survival was not significantly increased by PTEN deletion.
  • PTEN deficiency augmented CD8(+) T cell cytotoxicity in allogeneic mixed lymphocyte reactions (MLRs) but not autologous MLRs.
  • PTEN-deficient T cells still required CD28 costimulation and were susceptible to anergy.

Conclusions:

  • PTEN deletion augments T cell activation and effector functions, including cytokine production and cytotoxicity.
  • PTEN inhibition is a potential strategy for immune potentiation, enhancing CD4(+) and CD8(+) T cell responses.
  • PTEN inhibition does not confer CD28 independence or anergy resistance in T cells.

More Related Videos

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.